This federal contract award, with the identification number SPE2DB20D1050|SPE2DB25FH33R, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $19,162.99 delivery order contract is for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The contract has a firm fixed price pricing type and an ultimate completion date of October 29, 2024.
Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
This contract award was not designated with any set-aside requirements, indicating open competition. As a leading provider of pharmaceutical and medical products to federal agencies, Amerisourcebergen's extensive federal contract portfolio demonstrates its critical role in supplying essential healthcare commodities to support military and other government healthcare programs.
Generated 2/2/25, 12:07 AM